About Apollo Neuroscience
Apollo Neuroscience is a private company based in Pittsburgh, Pennsylvania. It has reported $23,765,871 raised in five offerings on Form D since March 2018. Its chief executive is Kathryn Fantauzzi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 15, 2024 | Apr 30, 2024 | $500,000of $2.0M target | 1 | $500K | Debt, Options, Securities on exercise, Debt convertible into equityRule 506(b) | Form D ↗ |
| Feb 9, 2023 | Feb 22, 2023amended Apr 29, 2024 | $9,270,041of $15.0M target | 17 | $545K | Options, Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D/A ↗2 earlier filings |
| May 11, 2021 | May 25, 2021amended Sep 30, 2021 | $8,005,730of $15.0M target | 17 | $470K | Equity, Series A Preferred Stock and the Common Stock issuable upon conversion thereof.Rule 506(b) | Form D/A ↗1 earlier filing |
| Jun 18, 2018 | Jul 3, 2018amended Feb 12, 2021 | $5,890,100fully sold | 51 | $115K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Mar 14, 2018 | Mar 28, 2018 | $100,000of $250K target | 1 | $100K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $23,765,871 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Apollo Neuroscience's Form D filed Apr 30, 2024.
GJ
Gary Johnson
Director
AC
Alan Cannistraro
Executive officer and director
KF
Kathryn Fantauzzi
CEO and director
DR
David Rabin
Executive officer and director
SS
Sa'ad Shah
Director
Sources
- SECApollo Neuroscience, Inc. Form D/A, filed Oct 12, 2023
- SECApollo Neuroscience, Inc. Form D, filed Feb 22, 2023
- SECApollo Neuroscience, Inc. Form D, filed May 25, 2021
- SECApollo Neuroscience, Inc. Form D/A, filed May 7, 2020
- SECApollo Neuroscience, Inc. Form D, filed Jul 3, 2018
- SECApollo Neuroscience, Inc. filing history